![](https://ml.globenewswire.com/media/c012733e-cc0c-4bb4-a1c1-55dddcc7d090/small/new-veronacorp-logo-inline-with-rgb-for-notfied-jpg.jpg)
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects Conference call tomorrow at 8:30 a.m. EDT / 1:30 p.m. …